Logo
O

OCON Therapeutics

22 employees

Our mission is to introduce innovative, high-quality an intrauterine drug-delivery technology to improve women’s health and quality of life

Basic info

Industry

pharmaceutical manufacturing

Sectors

Pharmaceutical
ball contraception
Ballerine
hysterectomy
Women's Lifestyle
Non-hormonal contraception
baby planning
LARC
Healthcare
The SEAD
innovative contraception
Gynecology
sexual health
bio investments
family planning
OBGYN
Intrauterine
Contraception
Abnormal uterine bleeding
GP
Health Care
AUB
Drug Products
hormone-free contraception
IUB
non surgical therapy
IUD
birth control
Women's Health

Date founded

2020

Funding rounds raised

Total raised

$15M

from 4 investors over 4 rounds

O

OCON Therapeutics raised $4.5M on December 31, 2020

Investors: Merchavia Holdings and Investments Ltd and Rhia Ventures

O

OCON Therapeutics raised $15M on January 29, 2016

Investors: DOCOR and Pontifax Venture Capital

FAQ